Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Rolf P, Kreutz"'
Autor:
Nicholas R. Powell, Tyler Shugg, Jacob Leighty, Matthew Martin, Rolf P. Kreutz, Michael T. Eadon, Dongbing Lai, Tao Lu, Todd C. Skaar
Publikováno v:
Chronic Diseases and Translational Medicine, Vol 10, Iss 2, Pp 102-117 (2024)
Abstract Background Hypertension (HTN) involves genetic variability in the renin‐angiotensin system and influences antihypertensive response. We previously reported that angiotensinogen (AGT) messenger RNA (mRNA) is endogenously bound by miR‐122
Externí odkaz:
https://doaj.org/article/3ddeee81c38249dfbeaa61315455683e
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 8, Pp 1946-1958 (2022)
Abstract MicroRNAs (miRNAs) are small RNAs integral in the regulation of gene expression. Analysis of circulating miRNA levels may identify patients with coronary artery disease (CAD) at risk for recurrent myocardial infarction (MI) after percutaneou
Externí odkaz:
https://doaj.org/article/fba3b64bf7a140a8aad06bcb18ca1359
Autor:
Amber L. Beitelshees, Cameron D. Thomas, Philip E. Empey, George A. Stouffer, Dominick J. Angiolillo, Francesco Franchi, Sony Tuteja, Nita A. Limdi, James C. Lee, Julio D. Duarte, Rolf P. Kreutz, Todd C. Skaar, James C. Coons, Jay Giri, Caitrin W. McDonough, Rachel Rowland, James M. Stevenson, Thuy Thai, Mark R. Vesely, Jacob T. Wellen, Julie A. Johnson, Almut G. Winterstein, Larisa H. Cavallari, Craig R. Lee
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 4 (2022)
Background Studies have demonstrated increased risk of major atherothrombotic events in CYP2C19 loss‐of‐function (LOF) variant carriers versus non‐carriers treated with clopidogrel after percutaneous coronary intervention (PCI). We sought to ev
Externí odkaz:
https://doaj.org/article/fdde104f3e8e43f68d0603d9571a4e08
Publikováno v:
Catheterization and Cardiovascular Interventions. 101:995-1000
Publikováno v:
Thrombosis Research. 226:156-158
Autor:
Rahul Chaudhary, Kevin P. Bliden, Rolf P. Kreutz, Young-Hoon Jeong, Udaya S. Tantry, Jerrold H. Levy, Paul A. Gurbel
Publikováno v:
EClinicalMedicine, Vol 29, Iss , Pp 100647- (2020)
Externí odkaz:
https://doaj.org/article/4b3e28b2f33341009332b3062c5a731e
Autor:
Nicholas R. Powell, Tyler Shugg, Jacob Leighty, Matthew Martin, Rolf P. Kreutz, Michael T. Eadon, Dongbing Lai, Tao Lu, Todd C. Skaar
Hypertension (HTN) involves genetic variability in the renin-angiotensin system and characterizing this variability will help advance precision antihypertensive treatments. We previously reported that angiotensinogen (AGT) mRNA is endogenously bound
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4de4f755f636e08ffa4b3a1b7beeee1f
https://doi.org/10.1101/2023.04.07.536073
https://doi.org/10.1101/2023.04.07.536073
Autor:
Rolf P. Kreutz, Glen Schmeisser, Andrea Schaffter, Sri Kanuri, Janelle Owens, Benjamin Maatman, Anjan Sinha, Elisabeth von der Lohe, Jeffrey A. Breall
Publikováno v:
TH Open, Vol 02, Iss 02, Pp e173-e181 (2018)
Abstract Background High plasma fibrin clot strength (MA) measured by thrombelastography (TEG) is associated with increased risk of cardiac events after percutaneous coronary interventions (PCIs). Factor XIIIa (FXIIIa) cross-links soluble fibrin, s
Externí odkaz:
https://doaj.org/article/aa8cfbbda8104766b46e320b938594e6
Publikováno v:
Journal of Diabetes Research, Vol 2018 (2018)
Background. Patients with diabetes mellitus (DM) exhibit increased risk of recurrent myocardial infarction. Maximal clot strength measured by thrombelastography (TEG) is a risk factor for recurrent ischemic events. We hypothesized that diabetic subje
Externí odkaz:
https://doaj.org/article/78f38e62bd874ade9bdb864f9e5a62ac
Autor:
Ryan Mallory, Rolf P. Kreutz
Publikováno v:
JACC: Case Reports. 4:556-558
Isolated right ventricular myocardial infarctions (MIs) are rare, especially those presenting with anterior ST-segment elevation, which is normally seen in anterior MI. This occurs if the right coronary artery is nondominant. Differentiating between